These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 26753613)
21. Reprogramming of human cancer cells to pluripotency for models of cancer progression. Kim J; Zaret KS EMBO J; 2015 Mar; 34(6):739-47. PubMed ID: 25712212 [TBL] [Abstract][Full Text] [Related]
24. Identification of melanoma initiating cells: does CD271 have a future? Ballotti R Future Oncol; 2015; 11(11):1587-90. PubMed ID: 26043212 [No Abstract] [Full Text] [Related]
25. Epigenetic Aberrations Are Not Specific to Transcription Factor-Mediated Reprogramming. Tiemann U; Wu G; Marthaler AG; Schöler HR; Tapia N Stem Cell Reports; 2016 Jan; 6(1):35-43. PubMed ID: 26711876 [TBL] [Abstract][Full Text] [Related]
26. Reprogramming of Notch1-induced acute lymphoblastic leukemia cells into pluripotent stem cells in mice. Zhang H; Cheng H; Wang Y; Zheng Y; Liu Y; Liu K; Xu J; Hao S; Yuan W; Zhao T; Cheng T Blood Cancer J; 2016 Jul; 6(7):e444. PubMed ID: 27391576 [No Abstract] [Full Text] [Related]
27. Reprogramming human A375 amelanotic melanoma cells by catalase overexpression: Reversion or promotion of malignancy by inducing melanogenesis or metastasis. Bracalente C; Salguero N; Notcovich C; Müller CB; da Motta LL; Klamt F; Ibañez IL; Durán H Oncotarget; 2016 Jul; 7(27):41142-41153. PubMed ID: 27206672 [TBL] [Abstract][Full Text] [Related]
28. Sendai virus-mediated expression of reprogramming factors promotes plasticity of human neuroblastoma cells. Islam SM; Suenaga Y; Takatori A; Ueda Y; Kaneko Y; Kawana H; Itami M; Ohira M; Yokoi S; Nakagawara A Cancer Sci; 2015 Oct; 106(10):1351-61. PubMed ID: 26190440 [TBL] [Abstract][Full Text] [Related]
29. Partial reprogramming induces a steady decline in epigenetic age before loss of somatic identity. Olova N; Simpson DJ; Marioni RE; Chandra T Aging Cell; 2019 Feb; 18(1):e12877. PubMed ID: 30450724 [TBL] [Abstract][Full Text] [Related]
30. Dedifferentiated melanomas: Morpho-phenotypic profile, genetic reprogramming and clinical implications. Massi D; Mihic-Probst D; Schadendorf D; Dummer R; Mandalà M Cancer Treat Rev; 2020 Aug; 88():102060. PubMed ID: 32619863 [TBL] [Abstract][Full Text] [Related]
31. Stimulation of somatic cell reprogramming by ERas-Akt-FoxO1 signaling axis. Yu Y; Liang D; Tian Q; Chen X; Jiang B; Chou BK; Hu P; Cheng L; Gao P; Li J; Wang G Stem Cells; 2014 Feb; 32(2):349-63. PubMed ID: 23765875 [TBL] [Abstract][Full Text] [Related]
32. Malignant germ cell-like tumors, expressing Ki-1 antigen (CD30), are revealed during in vivo differentiation of partially reprogrammed human-induced pluripotent stem cells. Griscelli F; Féraud O; Oudrhiri N; Gobbo E; Casal I; Chomel JC; Biéche I; Duvillard P; Opolon P; Turhan AG; Bennaceur-Griscelli A Am J Pathol; 2012 May; 180(5):2084-96. PubMed ID: 22425713 [TBL] [Abstract][Full Text] [Related]
33. Induced pluripotent stem cell technology for dissecting the cancer epigenome. Semi K; Yamada Y Cancer Sci; 2015 Oct; 106(10):1251-6. PubMed ID: 26224327 [TBL] [Abstract][Full Text] [Related]
34. Plasticity of melanoma cells induced by neural cell crest conditions and three-dimensional growth. Ghislin S; Deshayes F; Lauriol J; Middendorp S; Martins I; Al-Daccak R; Alcaide-Loridan C Melanoma Res; 2012 Jun; 22(3):184-94. PubMed ID: 22454190 [TBL] [Abstract][Full Text] [Related]
35. Overlapping genes may control reprogramming of mouse somatic cells into induced pluripotent stem cells (iPSCs) and breast cancer stem cells. Mosca E; Cocola C; Sabour D; Pelucchi P; Bertalot G; Palumbo O; Carella M; Götte M; Schöler HR; Reinbold R; Zucchi I; Milanesi L In Silico Biol; 2010; 10(5-6):207-21. PubMed ID: 22430355 [TBL] [Abstract][Full Text] [Related]
36. The Epigenetic Reprogramming Roadmap in Generation of iPSCs from Somatic Cells. Brix J; Zhou Y; Luo Y J Genet Genomics; 2015 Dec; 42(12):661-70. PubMed ID: 26743984 [TBL] [Abstract][Full Text] [Related]
37. Reprogramming of endometrial adult stromal cells in the presence of a ROCK inhibitor, thiazovivin, could obtain more efficient iPSCs. Mohseni R; Shoae-Hassani A; Verdi J Cell Biol Int; 2015 May; 39(5):515-8. PubMed ID: 25490878 [TBL] [Abstract][Full Text] [Related]
38. Epigenetic regulation leading to induced pluripotency drives cancer development in vivo. Ohnishi K; Semi K; Yamada Y Biochem Biophys Res Commun; 2014 Dec; 455(1-2):10-5. PubMed ID: 25019993 [TBL] [Abstract][Full Text] [Related]